Amgen實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%): 開倉

Amgen 新聞

黃達傑 2025 Sep 29, 16:00

SOFI 股票預測:未來五年 SoFi 股票會在哪裡?

黃達傑 2025 Sep 29, 16:00

NIO 股票預測:NIO 今天下跌 5%,未來會怎樣?

張瑋庭 2025 Sep 29, 15:10

聯準會獨立性受壓:政治與權力鬥爭

盧昕穎 2025 Sep 29, 14:10

PIMCO 執行長警告川普關稅,強調資料中心商機

張瑋庭 2025 Sep 29, 13:10

金價飆升:各國央行與 ETF 成為主要推動力量

盧昕穎 2025 Sep 29, 10:10

聯準會降息能解就業市場之困? 剖析經濟逆風下的挑戰

黃達傑 2025 Sep 27, 16:00

比特幣價格預測:如何在台灣購買比特幣?

黃達傑 2025 Sep 23, 16:00

Fintech 股票值得關注:Nu Holdings(NU)股票、SOFI 股票

黃達傑 2025 Sep 21, 16:00

QBTS 股票今天上漲 11%:D-Wave Quantum Inc. 發生了什麼事?

黃達傑 2025 Sep 17, 16:00

最佳成長科技股票:CoreWeave (CRWV)、Salesforce (CRM)、Google、Nvidia

最新新聞

顯示更多
許景桓 2025 Sep 30, 01:20

潛在的政府關閉威脅美國關鍵經濟數據的延遲發布

許景桓 2025 Sep 29, 14:20

川普擬對外國電影徵收100%關稅:好萊塢的未來岌岌可危?

盧昕穎 2025 Sep 29, 10:20

克里夫蘭聯準銀行哈瑪克:通膨恐延至2028,呼籲維持限制性政策

陳昊然 2025 Sep 29, 06:20

巴菲特指標飆升至歷史新高:市場估值引發擔憂

林芷柔 2025 Sep 29, 04:20

美國亞洲盟友對投資承諾猶豫不決:南韓和日本重新評估

陳昊然 2025 Sep 29, 03:20

美國國債殖利率在聯準會政策不確定性與政府關門風險中前行

盧昕穎 2025 Sep 29, 02:20

納坦雅胡與川普會面:加薩和平新方案擺上檯面

許景桓 2025 Sep 29, 01:20

聯準會主席繼任:華勒 vs. 哈塞特 - 經濟學家的願望與政治現實

聯絡方式

點差

1.98

點差(%)

0.6669 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期一

13:31 - 19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期四

13:31-19:59

星期五

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

160372621312

流通股份

538361851

收益日期(下一個)

1999-11-22

現金殖利率 

2025-09-12

除息日

2025-08-22

遠期年股息率

9.52

遠期年現金殖利率

0.032

每股盈餘

12.22

了解有關此金融工具的詳細資訊

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

相關工具

資產
出售
購買
更改(%):
查看所有金融工具

最新教育文章

顯示更多
黃達傑 2025 Sep 29, 16:00

Intel 股票今天上漲 4%:如何在台灣交易 INTC 股票 CFD

黃達傑 2025 Sep 29, 16:00

外匯投資解釋:EUR/USD、USD/JPY、GBP/USD、USD/CAD

黃達傑 2025 Sep 27, 16:00

新加坡股市行情實時分析:新加坡有哪些藍籌股?

Trustpilot